189.47M
Market cap
9.74x
Current P/E
7.27x
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Genfit S. A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis.

Similar securities

Based on sector and market capitalization

Report issue